Results for tag: "Ehlers Danlos Syndrome Drug"

Ehlers Danlos Syndrome (EDS) is a group of inherited connective tissue disorders that affect the skin, joints, and blood vessel walls. It is caused by a defect in the production of collagen, a protein that provides structure and strength to the body's tissues. Immune Disorders Drugs are used to treat the symptoms of EDS, such as joint pain, fatigue, and skin fragility. These drugs can also help to reduce the risk of complications, such as organ damage and bleeding. Commonly prescribed medications include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and immunosuppressants. The Ehlers Danlos Syndrome Drug market is a rapidly growing sector of the pharmaceutical industry. Companies are investing in research and development to create new treatments for EDS, as well as to improve existing therapies. Some of the major players in the market include Pfizer, Novartis, Merck, and AbbVie. Show Less Read more